Interestingly, in two independent studies, siRNA-mediated knockdown of MED1 in melanoma and non-small cell lung cancer cells led to enhanced invasive properties in vitro by modulating metastasis-related genes such as the urokinase receptor/uPAR (10, 12). This evidence concerns the gene MED1 and melanoma.